Conivaptan hydrochloride

Pricing Availability   Qty
说明: Very high affinity vasopressin V1A and V2 antagonist; orally bioavailable
化学名: N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][benzazepin-6(1H)-yl)carbonyl]phenyl-[1,1'-biphenyl]-2-carboxamide hydrochloride
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for Conivaptan hydrochloride

Conivaptan hydrochloride is a very high affinity vasopressin V1A and V2 antagonist (Ki values are 0.61 and 0.66 - 3.04 nM, respectively). Inhibits vasopressin-induced pressor responses in rats without altering blood pressure, and increases urine flow while decreasing urine osmolality. Orally bioavailable.

化合物库 for Conivaptan hydrochloride

Conivaptan hydrochloride is also offered as part of the Tocriscreen 2.0 Max. 了解 Tocris 化合物库的更多信息。

技术数据 for Conivaptan hydrochloride

分子量 535.04
公式 C32H26N4O2.HCl
储存 Desiccate at RT
纯度 ≥98% (HPLC)
CAS Number 168626-94-6
PubChem ID 151171
InChI Key IKENVDNFQMCRTR-UHFFFAOYSA-N
Smiles CC1=NC2=C(C3=CC=CC=C3N(C(C4=CC=C(C=C4)NC(C5=C(C6=CC=CC=C6)C=CC=C5)=O)=O)CC2)N1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for Conivaptan hydrochloride

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 53.5 100
ethanol 10.7 20 温和加热

制备储备液 for Conivaptan hydrochloride

以下数据基于产品分子量 535.04。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 1.87 mL 9.35 mL 18.69 mL
5 mM 0.37 mL 1.87 mL 3.74 mL
10 mM 0.19 mL 0.93 mL 1.87 mL
50 mM 0.04 mL 0.19 mL 0.37 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for Conivaptan hydrochloride

参考文献 for Conivaptan hydrochloride

参考文献是支持产品生物活性的出版物。

Tahara et al (1997) Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo. J.Pharmacol.Exp.Ther. 282 301 PMID: 9223568

Yatsu et al (1997) Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs. Eur.J.Pharmacol. 321 225 PMID: 9063692


If you know of a relevant reference for Conivaptan hydrochloride, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Vasopressin Receptor Antagonists

关键词: Conivaptan hydrochloride, Conivaptan hydrochloride supplier, conivaptan, HCl, very, high, affinity, vasopressin, V1A, V2, antagonists, antagonism, AVP, orally, bioavailable, Vasopressin, Receptors, 6830, Tocris Bioscience

篇 Conivaptan hydrochloride 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 Conivaptan hydrochloride 的引用文献。 您是否知道使用了 Tocris Conivaptan hydrochloride 的优秀论文? 请告知我们.

Conivaptan hydrochloride 的评论

目前没有该产品的评论。 Be the first to review Conivaptan hydrochloride and earn rewards!

Have you used Conivaptan hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.